THE FEATURES OF DIAGNOSIS AND TREATMENT OF GLAUCOMA DURING PREGNANCY

Abstract


One of the important and completely unresolved issues of ophthalmology is the diagnosis and treatment of primary and secondary glaucoma in women during pregnancy and in the postpartum period. In the modern world more women give birth in adulthood, when pregnancy can be associated with an increased risk of the development and progression of glaucoma. The combination of glaucoma and pregnancy is a rare clinical situation and even less often glaucoma is detected during pregnancy. In childbearing age, the children’s and youthful form of glaucoma prevails among women, and may also be secondary, as a complication of other eye and systemic diseases. The IOP-reducing effect of pregnancy can mask glaucoma, that not diagnosed before it. The treatment of glaucoma of women during the pregnancy is still an unresolved problem due to fears of toxic effects, teratogenicity and side effects of drugs on the fetus, as well as on the course of the pregnancy itself. The study of the medicinal influence on the course of pregnancy is a difficult object, because there are not enough clinical cases due to a small number of patients. Influence of antihypertensive drugs in pregnant animals can not be an absolute confirmation of the safety of their use in humans. Therefore, a woman should be warned about the need for pregnancy planning and timely discussion of her management with a doctor. The review discusses diagnostic methods, the possibility of conservative, laser and surgical treatment of glaucoma during pregnancy in women.

Full Text

Restricted Access

About the authors

O. A Kiseleva

The Helmholtz Moscow Research Institute of Eye Diseases Russian Ministry of Health

105062, Moscow, Russian Federation

Liya V. Yakubova

The Helmholtz Moscow Research Institute of Eye Diseases Russian Ministry of Health

Email: yakoubova@yandex.ru
105062, Moscow, Russian Federation
senior research scientist for the Department of Glaucoma The Helmholtz Moscow Research Institute of Eye Diseases, Russian Ministry of Health, Moscow, 105062, Russian Federation

S. M Kosakyan

The Helmholtz Moscow Research Institute of Eye Diseases Russian Ministry of Health

105062, Moscow, Russian Federation

L. V Vasilenkova

The Helmholtz Moscow Research Institute of Eye Diseases Russian Ministry of Health

105062, Moscow, Russian Federation

References

  1. Шехтман М.M. Руководство по экстрагенитальной патологии у беременных. - Москва.: Триада; 2005.
  2. Wilensky J.T. Pregnancy and glaucoma. In: Higginbotham EJ, Lee DA (eds): Management of difficult Glaucoma. Boston: Blackwell Scientific; 1994; 246-9.
  3. Kearns P.P., Dhillon B.J. Angle closure glaucoma precipitated by labour. Acta Ophthalmol. 1990; 68: 225-6.
  4. Goldwyn R., Waltman S.R., Becker B. Primary open-angle glaucoma in adolescents and young adults. Arch Ophthalmol. 1970; 84: 579-82.
  5. Yoshidaa M., Okadaa E., Mizukib N. Age-specific prevalence of open-angle glaucoma and its relationship to refraction among more than 60,000 asymptomatic Japanese subjects. J. Clin. Epi. 2001; 54: 1151-8.
  6. Kass M.A., Sears M.L. Hormonal regulation of intraocular pressure. Surv. Ophthalmol. 1977; 22: 153-76.
  7. Posthumus R.G. The use and the possibilities of progesterone in the treatment of glaucoma. Ophthalmologica. 1952; 124:17-25.
  8. Sears M.L., Mead A. A major pathway for the regulation of intraocular pressure. Int. Opthalmol. Clin. 1983; 6: 201-12.
  9. Phillips C.I., Gore S.M. Ocular hypotensive effect of late pregnancy with and without high blood pressure. Br. J. Ophthalmol. 1985; 67: 117-9.
  10. Sunness J.S. The pregnant woman’s eye. Surv. Ophthalmol. 1988; 32: 219-38.
  11. Stacey C.B., Teresa C.C., Thomas H., The course of glaucoma during pregnancy. Arch Ophthalmol. 2006; 124: 1089-94
  12. Hernandez C.M., Feijoo J. G., A. Vidal F.F., Borrella S. F., Valdizan C. M., Bueso E. S., Sanchez J. G. Intraocular pressure, topical therapy and visual field in pregnancy. Poster presented at EGS 9-th congress. Madrid: 2010; (P3.22).
  13. Horven I., Gjonnaess H., Kroese A. Blood circulation changes in the eye and limbs with relation to pregnancy and female sex hormones. Acta Ophthalmol. 1976; 54: 203-7.
  14. Wilke K. Episcleral venous pressure and pregnancy. Acta Ophthalmol. 1975; 125: 40-5.
  15. Carvill M. Bitemporal contraction of the fields of vision in pregnancy. Am. J. Ophthalmol. 1923; 6: 885-91.
  16. Miller N.R., Newman N.J. Clinical Neuro-Ophthalmology., 5th Ed. Baltimore: Williams & Wilkins, 1998; 3: 1467-8.
  17. Reece A.A., Hobbins J.C., Mahoney M.J., et al. Medicine of the Fetus and Mother, 2nd Ed. Philadelphia: JB Lippincott, 1992; 327-46.
  18. Flach A.J. Glaucoma treatment and pregnancy (correspondence). Arch Ophthalmol. 1991; 109: 463.
  19. Zimmerman T.J., Kooner K.S., Kandarakis A.S., et al. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol. 1984; 102: 551-3.
  20. Karim S.M. Physiological role of prostaglandins in the control of parturation and menstruation. J. Reprod. Fertil Suppl. 1972; 16: 105.
  21. Sideris E.B., Yokochi K., Coceani F., et al. Prostaglandins and fetal cardiac output distribution in the lamb. Am J Physiol. 1985; 248: 853-8.
  22. Philips J.B., Lyrene R.K. Prostaglandins, related compounds, and the perinatal pulmonary circulation. Clin. Perinatol. 1984; 11: 565-79.
  23. Tatiane da Silva Dal Pizzol, Fl´avia Pozzobon Knop, Sotero Serrate Mengue. Prenatal exposure to misoprostol and congenital anomalies:Systematic review and meta-analysis. Reproductive Toxicology. 2006; 22: 666-71.
  24. Persaud T.V. The effects of prostaglandin F2 (alpha) on pregnancy and fetal development in mice. Toxicology. 1974; 2: 25-9.
  25. Chang M.C., Hunt D.M. Effect of prostaglandin F2 alpha on the early pregnancy of rabbits. Nature. 1972; 236: 120-1.
  26. Hilbelink D.R., Chen L.T., Lanning J.C., et al. Pregnancy and fetal development in hamsters treated with prostaglandin F2(alpha). Prostaglandins Leukotrienes Med 1982; 8: 399-402.
  27. Marco De S., Angela L., Brigida C., et al. Latanoprost exposure in pregnancy. Am J Ophthalmol. 2004; 138: 305-6.
  28. Rayburn W.F., Zuspan F.P. Drug Therapy in Obstetrics and Gynecology, 3d Ed. St. Louis: Mosby Year Book, 1992; 194-7.
  29. Киселева О.А., Якубова Л.В., Бессмертный А.М. Бета-блокаторы в современной терапии глаукомы. Обзор. Офтальмология. 2013; 10 (2): 20-3.
  30. Schocken D.D., Caron M.G., Lefkowitz R.J. The human placenta. A rich source of beta-adrenergic receptors: characterization of the receptors in particulate and solubilized preparations. J. Clin. Endocrinol. Metab. 1980; 50: 1082-8.
  31. Barnett D.B., Cook N., Nahorski S.R. Heterogeneity of - adrenoreceptor subtypes in the human placenta. J. Auton. Pharmacol. 1982; 2: 103-10.
  32. Schneider H., Proegler M. Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue. Am. J. Obstet. Gynecol. 1988; 159(1): 42-7.
  33. Blaul G. [Local beta blockaders in pregnancy]. Klin. Monatsbl. Augenheilk. 1985; 187: 57-9.
  34. Butters L., Kennedy S., Rubin P.C. Atenolol in essential hypertension during pregnancy. Br. J. Med. 1990; 301: 587-9.
  35. Fishman W.H., Chesner M. Beta-adrenergic blockers in pregnancy. Am. Heart J. 1988; 115: 147.
  36. Boutroy M.J., Morselli P.L., Bianchetti G., et al. Betaxolol: a pilot study of its pharmacological and therapeutic properties in pregnancy. Eur. J. Clin. Pharmacol. 1990; 38: 535-9.
  37. Lustgarten J.S., Podos S.M. Topical timolol and the nursing mother. Arch Ophthalmol. 1983; 101: 1381-2.
  38. Kuzelova M., Jurinova J., Jencova D., et al. Development of a withdrawal syndrome in a neonate after long-term therapy of a mother with metipranolol during pregnancy. Cesk Pediatr. 1993; 48: 608-10.
  39. Woods D.L., Morrell D.F. Atenolol: side effects in a newborn infant. Br Med J. 1982; 285: 691-2.
  40. Williams T., Ginther W.H. Hazard of ophthalmic timolol. N. Engl. J. Med. 1982; 306: 1485-6.
  41. Burnstine R.A., Felton J.L., Ginther W.H. Cardiorespiratory reaction to timolol maleate in a pediatric patient: a case report. Ann. Ophthalmol. 1982; 14(10): 905-6.
  42. Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics. 1994; 93(1): 137-50.
  43. Samples J.R., Meyer S.M. Use of ophthalmic medications in pregnant and nursing women. Am. J. Ophthalmol. 1988; 106(5): 616-23.
  44. King R.G., Gude N.M., Krishna B.R., et al. Human placental acetylcholine. Reprod Fertil Dev. 1991; 3(4): 405-11.
  45. Sastry B.V. Human placental cholinergic system. Biochem. Pharmacol. 1997; 53(11): 1577-86.
  46. Landauer W. The teratogenic activity of pilocarpine, pilocarpidine and their isomers, with special reference to the importance of steric configuration. J. Exp. Zool. 1956; 132: 39-50.
  47. Chew E.Y., Trope G.E., Mitchell B.J. Diurnal intraocular pressure in young adults with central retinal vein occlusion. Ophthalmology. 1987; 94: 1545-49.
  48. Morgan C.D., Sandler M., Panigel M. Placental transfer of catacholamines in vitro and in vivo. Am. J. Obstet. Gynecol. 1972; 112: 1068-75.
  49. Rosenfeld C.R., Barton M.D., Meschia G. Effects of epinephrine on distribution of blood flow in the pregnant ewe. Am. J. Obstet. Gynecol. 1976; 124: 156-63.
  50. Gardey-Levassort C., Ventura M.A., Thiroux G., et al. An attempt to identify - adrenoceptors in the human placenta. Dev. Pharmacol. Ther. 1984; 7(1): 85-8.
  51. Lien E.L., Morrison A., Kassarich J., et al. Alpha-2-adrenergic control of prolactin release. Neuroendocrinology. 1986; 44(2): 184-9.
  52. Holmes L.B., Kawanishi H., Munoz A. Acetazolamide: maternal toxicity, pattern of malformations, and litter effect. Teratology. 1988; 37: 195-202.
  53. Scott W.J., Hirsh K.S., DeSesso J.M., et al. Comparative studies on acetazolamide teratogenesis in pregnant rats, rabbits, and rhesus monkeys. Teratology. 1981; 24: 37-42.
  54. Heinonen O.P., Slone D., Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, 1977; 372.
  55. Merlob P., Litwin A., Mor N. Possible association between acetazolamide administration during pregnancy and metabolic disorders in the newborn. Eur. J.Obstet. Gynecol. Reprod. Biol. 1990; 35: 85-8.
  56. Lee A.G., Pless M., Falardeau J., Capozzoli T., Wall M., Kardon R.H. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J. Ophthalmol. 2005; 139: 855-9.
  57. Ozawa H., Azuma E., Shindo K., Higashigawa M., Mukouhara R., Komada Y. Transient renal tubular acidosis in a neonate following transplacental acetazolamide. Eur. J. Pediatr. 2001; 160: 321-2.
  58. Craft I.L., Musa B.D. Hypertonic solutions to induce abortion. Br. Med.J. 1971; 2(752): 49.
  59. Petter C. Lesions des extremities provoquees chez le foetus de rat par des injections intraveineuses de mannitol hypertonique a la mere. CR. Soc. Biol. 1967; 161: 1010-4.
  60. Lasuncion M.A., Lorenzo J., Palacin M., et al. Maternal factors modulating nutrient transfer to fetus. Biol. Neonate. 1987; 51: 86-93.
  61. Sherwood M.B., Migdal C.S., Hitchings R.A. Initial treatment of glaucoma: surgery or medications/ Filtration surgery. Surv. Ophthalmol. 1993; 37: 293-9.
  62. Wertheim M., Broadway D. C. Cyclodiode laser therapy to control intraocular pressure during pregnancy. Br. J. Ophthalmol. 2002; 86: 1318-9.
  63. Flach A.J. The Importance of Eyelid Closure and Nasolacrimal Occlusion Following the Ocular Instillation of Topical Glaucoma Medications, and the Need for the Universal Inclusion of One of these Techniques in All Patient Treatments and Clinical Studies. Trans. Am. Ophthalmol. Soc. 2008; 106: 138-48.
  64. Киселева О.А., Косакян С.М., Якубова Л.В., Василенкова Л.В. Лекарственные взаимодействия антиглаукомных препаратов на фоне общих хронических заболеваний. Клиническая офтальмология. 2016; № 1: 16-9.

Statistics

Views

Abstract - 12

PDF (Russian) - 0

Cited-By


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies